• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stenosis (2263); Obstruction/Occlusion (2422); Pseudoaneurysm (2605)
Event Date 11/01/2011
Event Type  Injury  
Manufacturer Narrative
Date of event, implant date: dates estimated.The patient deaths and device malfunctions referenced will be filed under separate medwatch report #s.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.A definitive cause for the reported stenosis, occlusion, pseudoaneurysm and amputation and the relationship to the product, if any, cannot be determined.The reported patient effects of stenosis, occlusion, pseudoaneurysm, and amputation are listed in the supera instructions for use as known potential patient effects associated with the use of the device.Based on the information reported through the research article, a definitive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported unexpected medical intervention and hospitalization were likely related to case circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.The udi is unknown as the part and lot numbers were not provided.Article title: a midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents.
 
Event Description
It was reported through a research article identifying supera that may be related to the following: patient death, restenosis, occlusion, pseudoaneurysm, elongation, malposition, amputation, revascularization, and rehospitalization.This article summarizes clinical outcomes of 315 patients that were treated with supera stents.Specific patient information is documented as unknown.Details are listed in the attached article, titled "a midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12359528
MDR Text Key267866232
Report Number2024168-2021-07446
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeHK
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA
Device Lot NumberUNKNOWN SUPERA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/05/2021
Initial Date FDA Received08/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age78 YR
-
-